Ozagrel

Description

Ozagrel is a thromboxane synthase inhibitor which is available in both tablet and injection forms. The injection form is used to improve movement disorder associated with cerebral thrombosis, cerebrovascular spasms, and symptoms associated with cerebral ischemia followed by surgery. The tablet form of this medicine is used for the treatment of bronchial asthma.

Side effects

Major & minor side effects for Ozagrel

  • Itching and skin rash
  • Nausea
  • Stomach discomfort
  • Loss of appetite
  • Yellowing of skin and eyes
  • Headache
  • Bleeding

Uses of Ozagrel

What is it prescribed for?

  • Bronchial asthma
  • Cerebral Ischemia
  • Movement disorder
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required for this medicine to show its action is not clinically established.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to ozagrel or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine.
General warnings

Use in Children

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established. However, your doctor may prescribe this medicine if the benefits significantly outweigh the risks. In such a case, the patient should be monitored closely for any adverse effects.

Other medicines

Ozagrel may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

Missed Dose

Injection:- Since this medicine is administered in the hospital or clinical setting by a qualified health care professional, the likelihood of a missed dose is very low. Tablet:- Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Injection:- Since this medicine is administered in the hospital or clinical setting by a qualified health care professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected. Tablet:- Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Bleeding disorders

This medicine should be used with an extreme cause in patients with bleeding disorders like hemorrhagic cerebral infarction, epidural bleeding, cerebral embolism, heart problem, etc due to the increased risk of worsening of the patient's condition. An alternative treatment option should be considered in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Injection: This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine. Tablet:- Take this medicine following all labeled instructions. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

To be taken after food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by inhibiting some type of metabolites which are responsible for vasoconstriction, bronchoconstriction and platelet aggregation.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Thromboxane synthase inhibitor

Schedule

Schedule H

[Internet]. Rad-ar.or.jp. 2018 [cited 28 September 2018]. Available from:

http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=38092

[Internet]. Rad-ar.or.jp. 2018 [cited 28 September 2018]. Available from:

http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=2180

[Internet]. Ncbi.nlm.nih.gov. 2018 [cited 28 September 2018]. Available from:

https://www.ncbi.nlm.nih.gov/pubmed/3093741

[Internet]. Resources.rndsystems.com. 2018 [cited 28 September 2018]. Available from:

https://resources.rndsystems.com/pdfs/tocris_coa/1510_3_coa.pdf?t=1538133410

[Internet]. Sigmaaldrich.com. 2018 [cited 28 September 2018]. Available from:

https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/2/o1385pis.pdf

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 22 Aug 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.